DOP2013000030A - Compuesto heterociclico y su uso - Google Patents

Compuesto heterociclico y su uso

Info

Publication number
DOP2013000030A
DOP2013000030A DO2013000030A DO2013000030A DOP2013000030A DO P2013000030 A DOP2013000030 A DO P2013000030A DO 2013000030 A DO2013000030 A DO 2013000030A DO 2013000030 A DO2013000030 A DO 2013000030A DO P2013000030 A DOP2013000030 A DO P2013000030A
Authority
DO
Dominican Republic
Prior art keywords
compound
heterociclical
saies
isoxazolepropionic
adhd
Prior art date
Application number
DO2013000030A
Other languages
English (en)
Inventor
Osamu Ujikawa
Masakuni Kori
Eiji Honda
Toshihiro Imaeda
Shinji Nakamura
Masashi Toyofuku
Yasutomi Asano
Michiyo Mochizuki
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of DOP2013000030A publication Critical patent/DOP2013000030A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporciona un compuesto representado por la fórmula (l): en donde cada símbolo es como se define en la memoria descriptiva o una de sus saies, que tiene una acción potenciadora del receptor de AM PA (ácido a—amino—3—h idroxi—5—metil—4—isoxazolpropiónico). El compuesto de la presente invención es de utilidad como un fármaco preventivo o terapéutico para depresión, esquizofrénia, enfermedad de Alzheimer o trastorno de hiperactividad de déficit de atención (ADHD), y sim ilares.
DO2013000030A 2010-08-10 2013-02-05 Compuesto heterociclico y su uso DOP2013000030A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10

Publications (1)

Publication Number Publication Date
DOP2013000030A true DOP2013000030A (es) 2013-03-15

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2013000030A DOP2013000030A (es) 2010-08-10 2013-02-05 Compuesto heterociclico y su uso

Country Status (39)

Country Link
US (11) US8575154B2 (es)
EP (1) EP2603513B1 (es)
JP (2) JP5788496B2 (es)
KR (1) KR101852215B1 (es)
CN (2) CN103180326B (es)
AR (1) AR082618A1 (es)
AU (1) AU2011290126B2 (es)
BR (1) BR112013002250B1 (es)
CA (1) CA2807460C (es)
CL (1) CL2013000380A1 (es)
CO (1) CO6680700A2 (es)
CR (1) CR20130066A (es)
CY (1) CY1123507T1 (es)
DK (1) DK2603513T3 (es)
DO (1) DOP2013000030A (es)
EA (1) EA022078B1 (es)
EC (1) ECSP13012478A (es)
ES (1) ES2793723T3 (es)
GE (1) GEP20156216B (es)
HR (1) HRP20200844T1 (es)
HU (1) HUE049460T2 (es)
IL (1) IL224452A (es)
LT (1) LT2603513T (es)
MA (1) MA34509B1 (es)
MX (1) MX349470B (es)
MY (1) MY165908A (es)
NZ (1) NZ607593A (es)
PE (1) PE20131116A1 (es)
PH (1) PH12013500247A1 (es)
PL (1) PL2603513T3 (es)
PT (1) PT2603513T (es)
RS (1) RS60311B1 (es)
SG (1) SG187656A1 (es)
SI (1) SI2603513T1 (es)
TW (1) TWI504604B (es)
UA (1) UA111594C2 (es)
UY (1) UY33551A (es)
WO (1) WO2012020848A1 (es)
ZA (1) ZA201301120B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR082618A1 (es) * 2010-08-10 2012-12-19 Takeda Pharmaceutical Derivados de tiadiazina, composiciones farmaceuticas y usos
JP5976011B2 (ja) * 2011-04-05 2016-08-23 武田薬品工業株式会社 スルホンアミド誘導体およびその用途
EP2813508B1 (en) * 2012-02-08 2018-01-31 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US20150011554A1 (en) * 2013-06-13 2015-01-08 Veroscience Llc Compositions and Methods for Treating Metabolic Disorders
TN2015000547A1 (fr) 2013-06-27 2017-04-06 Pfizer Composes heteroaromatiques et leur utilisation comme ligands de dopamine d1
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
CA2931961C (en) 2013-12-03 2023-10-31 Andrew Duncan Satterfield Pyrrolidinones as herbicides
MX389921B (es) 2014-07-02 2025-03-20 Fmc Corp Star Herbicidas de piperidinona.
JP6611816B2 (ja) 2014-12-08 2019-11-27 エフ エム シー コーポレーション ３−オキソ−３−（アリールアミノ）プロパノエイト、その製造方法、およびピロリジノンの製造におけるその使用
AU2016246410B2 (en) 2015-04-10 2020-11-05 Fmc Corporation Substituted cyclic amides as herbicides
RU2734932C2 (ru) 2015-04-27 2020-10-26 ЭфЭмСи Корпорейшн Бутиролактоны в качестве гербицидов
HUE053943T2 (hu) 2015-04-29 2021-08-30 Janssen Pharmaceutica Nv Azabenzimidazolok és ampa receptor modulátorokként való alkalmazásuk
CN107567452B (zh) * 2015-04-29 2020-07-07 詹森药业有限公司 咪唑并哌嗪和吡唑并嘧啶以及它们作为ampa受体调节剂的用途
CA2980643C (en) 2015-05-12 2023-10-17 E I Du Pont De Nemours And Company Aryl substituted bicyclic compounds as herbicides
EP3303287B1 (en) 2015-05-29 2020-12-16 FMC Corporation Substituted cyclic amides as herbicides
JP6949730B2 (ja) 2015-06-02 2021-10-13 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 置換環状アミドおよび除草剤としてのそれらの使用
RU2720994C2 (ru) 2015-07-31 2020-05-15 Е.И.Дюпон Де Немур Энд Компани Новые соединения циклического n-карбоксамида, применяемые в качестве гербицидов
SI3331892T1 (sl) * 2015-08-06 2019-10-30 Hoffmann La Roche Postopki za pripravo derivatov gaINAc kisline
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
ES2958741T3 (es) 2016-12-21 2024-02-14 Fmc Corp Herbicidas de nitrona
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用，药物组合物
UA126576C2 (uk) 2017-03-21 2022-11-02 ЕфЕмСі КОРПОРЕЙШН Гербіцидна суміш, композиція та спосіб
KR102620213B1 (ko) 2017-03-21 2024-01-03 에프엠씨 코포레이션 피롤리디논 및 이의 제조 방법
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
WO2019070043A1 (ja) 2017-10-06 2019-04-11 武田薬品工業株式会社 複素環化合物
EP3693360B1 (en) * 2017-10-06 2023-12-13 Takeda Pharmaceutical Company Limited Heterocyclic compounds
US12370192B2 (en) 2019-09-16 2025-07-29 Takeda Pharmaceutical Company Limited Azole-fused pyridazin-3(2H)-one derivatives
TW202207944A (zh) * 2020-05-15 2022-03-01 日商武田藥品工業股份有限公司 抑鬱症之治療
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025226581A1 (en) 2024-04-22 2025-10-30 Neurocrine Biosciences, Inc. Osavampator for use in the treatment of depressive disorders and cognitive impairment

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (es) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
EP1229786A1 (en) 1999-11-04 2002-08-14 Colorado State University Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2458388A1 (en) 2001-10-10 2003-04-17 Neurosearch A/S Novel benzothiazine derivatives, their preparation and use
FR2833955B1 (fr) 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2007262661A1 (en) 2006-06-23 2007-12-27 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
AU2007333247B2 (en) * 2006-12-11 2012-06-07 Eli Lilly And Company AMPA receptor potentiators
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
CN101910178A (zh) 2007-11-05 2010-12-08 先灵公司 γ分泌酶调节剂
JP2011507910A (ja) * 2007-12-21 2011-03-10 ユニバーシティー オブ ロチェスター 真核生物の寿命を変更するための方法
JPWO2009119088A1 (ja) 2008-03-25 2011-07-21 武田薬品工業株式会社 複素環化合物
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) * 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
WO2010054078A1 (en) 2008-11-06 2010-05-14 Schering Corporation Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
CA2767764A1 (en) 2009-07-13 2011-01-20 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
AR082618A1 (es) * 2010-08-10 2012-12-19 Takeda Pharmaceutical Derivados de tiadiazina, composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
AU2011290126A1 (en) 2013-03-07
BR112013002250B1 (pt) 2020-10-27
PE20131116A1 (es) 2013-10-24
US8575154B2 (en) 2013-11-05
HUE049460T2 (hu) 2020-09-28
LT2603513T (lt) 2020-05-25
KR20130138738A (ko) 2013-12-19
IL224452A (en) 2017-11-30
AU2011290126B2 (en) 2016-01-07
DK2603513T3 (da) 2020-06-15
US8778934B2 (en) 2014-07-15
EA022078B1 (ru) 2015-10-30
WO2012020848A1 (en) 2012-02-16
MA34509B1 (fr) 2013-09-02
CA2807460A1 (en) 2012-02-16
BR112013002250A2 (pt) 2016-05-24
US20170022222A1 (en) 2017-01-26
ES2793723T3 (es) 2020-11-16
CA2807460C (en) 2018-09-18
US9150591B2 (en) 2015-10-06
US20180162875A1 (en) 2018-06-14
US20200317692A1 (en) 2020-10-08
CN103180326B (zh) 2015-06-10
US9499568B2 (en) 2016-11-22
JP2016006080A (ja) 2016-01-14
EP2603513A1 (en) 2013-06-19
US11279713B2 (en) 2022-03-22
JP2013535408A (ja) 2013-09-12
JP6113789B2 (ja) 2017-04-12
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
RS60311B1 (sr) 2020-07-31
US20140080817A1 (en) 2014-03-20
US20150073137A1 (en) 2015-03-12
PT2603513T (pt) 2020-06-08
EA201390222A1 (ru) 2013-08-30
CO6680700A2 (es) 2013-05-31
NZ607593A (en) 2015-01-30
US8916551B2 (en) 2014-12-23
US9884875B2 (en) 2018-02-06
WO2012020848A8 (en) 2012-09-27
TW201217386A (en) 2012-05-01
MY165908A (en) 2018-05-18
AR082618A1 (es) 2012-12-19
KR101852215B1 (ko) 2018-04-25
CN104926837A (zh) 2015-09-23
ECSP13012478A (es) 2013-04-30
US20150353578A1 (en) 2015-12-10
US20130184266A1 (en) 2013-07-18
CN103180326A (zh) 2013-06-26
CR20130066A (es) 2013-05-03
US20130190291A1 (en) 2013-07-25
MX349470B (es) 2017-07-31
US20120077799A1 (en) 2012-03-29
JP5788496B2 (ja) 2015-09-30
UY33551A (es) 2012-03-30
CL2013000380A1 (es) 2013-05-31
US20240360156A1 (en) 2024-10-31
PL2603513T3 (pl) 2020-07-27
US20190263832A1 (en) 2019-08-29
CY1123507T1 (el) 2022-03-24
US10654874B2 (en) 2020-05-19
PH12013500247A1 (en) 2013-03-11
SG187656A1 (en) 2013-03-28
TWI504604B (zh) 2015-10-21
HRP20200844T1 (hr) 2020-08-21
MX2013001614A (es) 2013-07-05
EP2603513B1 (en) 2020-03-11
ZA201301120B (en) 2014-04-30
GEP20156216B (en) 2015-01-12

Similar Documents

Publication Publication Date Title
DOP2013000030A (es) Compuesto heterociclico y su uso
MX2019003738A (es) Compuestos antivirales.
ECSP14013329A (es) Compuestos de arylcarbonil-4-oxy-piperidina utilizados para el tratamiento de enfermedades neurodegenerativas
GT201200220A (es) Ciertas triazolopiridinas y triazolopirazinas, composiciones de estas y sus métodos de empleo
CR20110103A (es) Heteroarilos sustituidos
CL2014000210A1 (es) Una composicion de prodroga que comprende al menos un conjugado de metilfenidato; kit farmaceutico que la comprende, util para el tratamiento de una enfermedad o condicion que requiere estimulacion del sistema nervioso tal como un trastorno de hiperactividad con deficit de atencion y depresion.
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
CO6430427A2 (es) Derivados de benzofuranilo
MX2016003199A (es) Compuestos de azapiridona y usos de los mismos.
NI201000035A (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de histamina-3
CO7071139A2 (es) Tratamiento contra el cáncer cerebral
CO7350640A2 (es) Compuestos diméricos
ECSP10010025A (es) Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina-3
DOP2010000321A (es) Derivados de iminopirimidina y su uso
CO6341625A2 (es) Derivados de indol como agentes anticáncer
CO6491037A2 (es) Derivados de pirazinooxazepina
CL2017000069A1 (es) Derivado de hidantoina.
CL2016000884A1 (es) Derivados de piperazina y su uso como medicamento.
CR20150148A (es) Azaindolinas
MX2012007395A (es) Compuesto de anillo de siete miembros y uso farmaceutico para el mismo.
BR112013000941A2 (pt) formulações de 14-epi-análogos de vitamina d
BR112017011777A2 (pt) antagonista de a2a de dosagem baixa para o tratamento de tdah e doença de parkinson
CU20110020A7 (es) Compuestos de fenantrenona, composiciones y métodos
UY32448A (es) Derivados de 3-benzofuranil-indol-2-ona-3-acetamidopiperazinas sustituidos, su preparacion y su aplicacion en terapeutica
SMT201600466T1 (it) Facetoperano per il trattamento del disturbo da deficit di attenzione/iperattività